EPHX2 and cardiac hypertrophy: In Ephx2 (−/−) mouse experiments, sEH deletion reduced bFGF expression in cardiac tissues by inhibiting MAPK activation, thereby alleviating mouse cardiac hypertrophy (Zhang et al., 2014).